TRAF-mediated TNFR-family signaling.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 19918944)

Published in Curr Protoc Immunol on November 01, 2009

Authors

Hyunil Ha1, Daehee Han, Yongwon Choi

Author Affiliations

1: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Articles citing this

A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol (2013) 2.60

The head-regeneration transcriptome of the planarian Schmidtea mediterranea. Genome Biol (2011) 1.41

Ubiquitin makes its mark on immune regulation. Immunity (2010) 1.25

Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation. Mol Biol Cell (2012) 1.07

KAP1 regulates gene networks controlling T-cell development and responsiveness. FASEB J (2012) 1.02

Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells. J Biol Chem (2012) 0.96

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses. J Exp Med (2013) 0.93

Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Front Genet (2014) 0.91

K63-linked ubiquitination in kinase activation and cancer. Front Oncol (2012) 0.87

TRAF6-mediated ubiquitination of NEMO requires p62/sequestosome-1. Mol Immunol (2013) 0.86

TRAF5 negatively regulates TLR signaling in B lymphocytes. J Immunol (2013) 0.83

TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η. Development (2014) 0.82

Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction. J Biol Chem (2015) 0.81

Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoprotein. J Biol Chem (2011) 0.80

Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Immunol Rev (2015) 0.78

Traf7, a MyoD1 transcriptional target, regulates nuclear factor-κB activity during myogenesis. EMBO Rep (2010) 0.78

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach. J Transl Med (2014) 0.77

Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders. PLoS One (2012) 0.77

Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation. Cell Signal (2010) 0.77

Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression. Sci Signal (2013) 0.76

MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma. Am J Transl Res (2016) 0.76

Roles of TRAF3 in T cells: many surprises. Cell Cycle (2015) 0.76

TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice. J Immunol (2012) 0.76

YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB. Elife (2017) 0.75

Articles by these authors

An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol (2003) 8.23

Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09

TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature (2011) 4.16

Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 3.82

v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med (2006) 3.78

Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol (2006) 3.18

Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol (2004) 2.79

Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood (2007) 2.65

Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol (2007) 2.61

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol (2010) 2.47

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A (2010) 2.45

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med (2006) 2.44

TRAF6 is a critical factor for dendritic cell maturation and development. Immunity (2003) 2.36

Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32

Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity (2002) 2.31

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol (2007) 2.25

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity (2002) 2.20

A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med (2002) 2.04

The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity (2006) 2.04

TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL. PLoS One (2008) 1.86

Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol (2002) 1.82

Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med (2009) 1.81

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br J Haematol (2002) 1.74

Computed tomography in pulmonary artery sarcoma: distinguishing features from pulmonary embolic disease. J Comput Assist Tomogr (2004) 1.73

Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem (2005) 1.62

Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57

GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48

OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol (2012) 1.43

Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood (2005) 1.38

OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest (2011) 1.38

Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J Immunol (2006) 1.37

TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem (2008) 1.31

Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep (2005) 1.30

Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med (2002) 1.29

The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem (2008) 1.29

Biology of the TRANCE axis. Cytokine Growth Factor Rev (2003) 1.29

Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell (2007) 1.29

Effect of monitor luminance and ambient light on observer performance in soft-copy reading of digital chest radiographs. Radiology (2004) 1.28

TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol (2005) 1.27

The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol (2002) 1.27

Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent. J Immunol (2002) 1.26

T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res (2006) 1.26

The role of TRAF6 in signal transduction and the immune response. Microbes Infect (2004) 1.23

Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest (2010) 1.17

IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation. J Exp Med (2005) 1.15

Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest (2009) 1.15

Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem (2003) 1.14

Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc Natl Acad Sci U S A (2011) 1.13

The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol (2012) 1.10

TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A (2004) 1.09

Osteoimmunology: interactions of the immune and skeletal systems. Mol Cells (2004) 1.09

Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metab (2013) 1.09

TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem (2001) 1.08

Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell (2012) 1.07

TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res (2003) 1.07

Osteoimmunology: cytokines and the skeletal system. BMB Rep (2008) 1.04

TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease. J Immunol (2003) 1.03

Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand. J Immunol (2006) 1.03

TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2. Blood (2010) 1.01

NHE10, an osteoclast-specific member of the Na+/H+ exchanger family, regulates osteoclast differentiation and survival [corrected]. Biochem Biophys Res Commun (2008) 1.00

Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. Immunity (2013) 1.00

Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol (2014) 0.99

Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression. Mol Cell Biol (2006) 0.98

Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol (2002) 0.98

TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii. Infect Immun (2004) 0.97

IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem (2012) 0.97

TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS One (2009) 0.96

RANKL induces organized lymph node growth by stromal cell proliferation. J Immunol (2011) 0.96

TRAF1 and its biological functions. Adv Exp Med Biol (2007) 0.96

Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J Immunol (2008) 0.95

Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene. Biochem Biophys Res Commun (2007) 0.95

The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res (2003) 0.93

Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo. J Biol Chem (2003) 0.93

Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation. J Biol Chem (2009) 0.92

Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J Biol Chem (2009) 0.91

The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging. J Thorac Imaging (2003) 0.90

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles. J Immunol (2005) 0.90

Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury. Mol Cell Biol (2012) 0.89

Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol Lett (2005) 0.89

Multidetector CT of bronchiectasis: effect of radiation dose on image quality. AJR Am J Roentgenol (2003) 0.89

TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity. PLoS One (2013) 0.87

EGR-2 is not required for in vivo CD4 T cell mediated immune responses. PLoS One (2010) 0.85

Osteoimmunology. Immunol Rev (2005) 0.85

TRAF-mediated TNFR-family signaling. Curr Protoc Immunol (2002) 0.84

TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells. Cell Immunol (2004) 0.84

The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. J Immunol (2004) 0.84

TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. J Immunol (2003) 0.83

Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. Hum Mol Genet (2013) 0.83

Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration. Int J Mol Med (2007) 0.82

Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts. J Cell Biol (2014) 0.82

TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development. Proc Natl Acad Sci U S A (2013) 0.82

Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation. Biochem Biophys Res Commun (2009) 0.80

Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur J Immunol (2010) 0.79

ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss. Biochem Biophys Res Commun (2010) 0.79

CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A. Int Immunol (2003) 0.78

Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation. Transpl Int (2009) 0.78

Correction: The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell-Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9-Producing T Cells. J Immunol (2015) 0.77